| 标题 |
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Diabetes & Endocrinology 作者:Thomas R. Pieber; Bruce W. Bode; Young Min Cho; Erik Christiansen; CHRISTIN L. HERTZ; et al 出版日期:2019-06-09 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)